tirzepatide vs tesamorelin Sermorelin: Which Growth Tesamorelin TRT Tirzepatide Combination: Visceral

The study found no clear differences between GLP-1 drugs and sodium-glucose cotransporter 2 inhibitors (SGLT2i) in terms of lean body mass loss

Be more cautious during dose increases, when digestive side effects are often more noticeable

Individual experiences vary, but the truth is, as with any medication, side effects are to be expected

Protocol 3: Rapid fat loss while maintaining performance Goal: Athletes or active people who need to lose fat without losing strength/performance Stack: AOD 9604: 500mcg daily (no appetite suppression) BPC-157: 500mcg twice daily TB-500: 5mg per week High protein, moderate carbs around training Maintain training intensity, reduce volume slightly Duration: 8-12 weeks Expected results: 12-20 pounds fat loss Maintained or improved performance Fast recovery despite calorie deficit Why this works: AOD for fat loss without appetite suppression (need to eat to fuel training)

Galkina E, Ley K

Common Side Effects include: Nausea or upset stomach Diarrhea or constipation Heartburn or acid reflux Mild fatigue Most of these symptoms are temporary and occur as the body adjusts to the increased GLP-1 levels